CAR-T Cell Therapy Market | Industry Analysis | Market Size | 2035

  The CAR-T Cell Therapy Market, 2021–2030 report features a comprehensive analysis of the current market landscape; the market is projected to be worth around USD 14 Billion, increasing at a CAGR of 28.9%, till 2030, envisions Roots Analysis. The market is anticipated to grow at a CAGR of over 28% during 2021–2030. Growth in this area is expected to be driven primarily by encouraging clinical trial results and the recent success of the four approved CAR-T cell therapies. North America (primarily the US) and Europe are expected to capture over 75% of the market share by 2030, in terms of sales-based revenues. Given their ability to selectively direct a cell-mediated immune reaction against cancer cells and, thereby, offer extended periods of disease remission, several CAR-T cell therapies deliver a promising therapeutic strategy for advanced-stage cancers and are expected to reach blockbuster status. With four approved products and many investigational therapy candidates addressing...